Package 0069-0353-30

{"route": ["ORAL"], "spl_id": "ab1b5af3-e7f1-46ac-8953-574c9924ccea", "openfda": {"upc": ["0300690353302", "0300690252308", "0300690757308", "0300690454306", "0300690546308"], "unii": ["02WK9U5NZC"], "rxcui": ["2099946", "2099952", "2099954", "2099956", "2591510", "2591512", "2591520", "2591521", "2639960", "2639962", "2639964", "2639966"], "spl_set_id": ["c6fd147f-a77e-4a0b-9280-e82ecc41b4be"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE, LIQUID FILLED in 1 BOTTLE (0069-0353-30)", "package_ndc": "0069-0353-30", "marketing_start_date": "20240417"}], "brand_name": "Talzenna", "product_id": "0069-0353_ab1b5af3-e7f1-46ac-8953-574c9924ccea", "dosage_form": "CAPSULE, LIQUID FILLED", "pharm_class": ["Poly(ADP-Ribose) Polymerase Inhibitor [EPC]", "Poly(ADP-Ribose) Polymerase Inhibitors [MoA]"], "product_ndc": "0069-0353", "generic_name": "talazoparib", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Talzenna", "active_ingredients": [{"name": "TALAZOPARIB TOSYLATE", "strength": ".25 mg/1"}], "application_number": "NDA217439", "marketing_category": "NDA", "marketing_start_date": "20240417", "listing_expiration_date": "20261231"}